Cell-mediated immunity (CMI) tests are used to diagnose (prior) infection by intracellular pathogens. A logistical hurdle of CMI tests is the fact that living cells are needed and hence blood needs to be stimulated within hours from collection. Supported by the Horizon2020 Research and Innovation program with academic and industrial partners from Wien, Oss, Leiden […]
€ 2 million for European Lyme Borreliosis innovation The European Union has granted almost € 2 million to an international consortium that will bring a novel Lyme Borreliosis test to market. The project is led by Innatoss Laboratories from the Netherlands, and combines knowledge from Austria, Germany and the Netherlands. The team will finalize a […]
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 720480
